JHIU
TPST icon

Janus Henderson Investors US’s Tempest Therapeutics TPST Stock Holding History

Janus Henderson Investors US’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10
Closed -$47K – 1202
2016
Q4 		$47K Sell
10
-1,313
-99% -$16.4M ﹤0.01% 1199
2016
Q3 		$27.7M Buy
1,323
+3
+0.2% +$54.3K 0.02% 539
2016
Q2 		$20.1M Buy
1,320
+144
+12% +$3.29M 0.02% 573
2016
Q1 		$32.7M Sell
1,176
-122
-9% -$2.58M 0.03% 492
2015
Q4 		$37.1M Sell
1,298
-17
-1% -$561K 0.03% 507
2015
Q3 		$32.7M Buy
1,315
+38
+3% +$2.56M 0.03% 503
2015
Q2 		$108M Buy
1,277
+187
+17% +$17.1M 0.09% 304
2015
Q1 		$111M Buy
1,090
+379
+53% +$50.5M 0.09% 287
2014
Q4 		$91.9M Buy
711
+119
+20% +$8.71M 0.08% 319
2014
Q3 		$28.7M Buy
592
+83
+16% +$2.91M 0.03% 523
2014
Q2 		$13.6M Buy
509
+24
+5% +$566K 0.01% 616
2014
Q1 		$12.7M Buy
485
+115
+31% +$3.26M 0.01% 625
2013
Q4 		$9.89M Buy
370
+12
+3% +$329K 0.01% 670
2013
Q3 		$10.4M Buy
358
+151
+73% +$5.36M 0.01% 642
2013
Q2 		$8.31M Buy
+207
New +$7.78M 0.01% 640

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Janus Henderson Investors US's TPST Position: Q1 2017 in Review

Janus Henderson Investors US sold out of Tempest Therapeutics (TPST) in Q1 2017, closing a stake of 10 shares — an estimated $47K sold.

Janus Henderson Investors US first reported a position in TPST in Q2 2013 and held it in 15 quarters. The position peaked at $111M in Q1 2015. 63 funds tracked by Wall St. Rank hold TPST as of Q1 2017.

  • Janus Henderson Investors US reported no remaining Tempest Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Janus Henderson Investors US sold 10 Tempest Therapeutics shares in Q1 2017, an estimated $47K.
  • Janus Henderson Investors US first reported a position in Tempest Therapeutics in Q2 2013 and held it in 15 quarters.
  • Janus Henderson Investors US's Tempest Therapeutics position peaked at $111M in Q1 2015.
  • 63 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.